FISH & Cytogenetics
Fluorescence in-situ hybridization and conventional karyotyping for chromosomal abnormalities critical to cancer classification and prognosis.
For Doctors
Clinical Overview
FISH and cytogenetic analysis provide essential chromosomal information for cancer risk stratification. We offer targeted FISH panels for AML, ALL, MDS, CLL, myeloma, and solid tumors (HER2, ALK). Conventional karyotyping complements FISH for comprehensive genetic profiling.
Key Test Panels
- FISH for Hematological Malignancies
- Conventional Karyotyping
- HER2 FISH (Breast Cancer)
Specimen Requirements
- Bone marrow aspirate (heparin)
- FFPE tissue sections
- Fresh tissue
Routine TAT
5-7 days
STAT TAT
3 days (FISH only)
For Patients
What This Detects
FISH testing looks at specific chromosomal changes in cancer cells under a specialized microscope. These changes help classify your cancer more precisely and determine whether certain targeted treatments will be effective.
What to Expect
- 1Your doctor will order the specific tests needed
- 2We collect or receive your sample
- 3Expert pathologists analyze and interpret results
- 4Your report is sent to your doctor within the stated TAT
- 5Your doctor will explain the results and next steps
Pricing
Call for pricing — +91-9873377575
Pricing varies by specific tests ordered and insurance coverage.
Related Departments
Hemato-Oncology
Comprehensive blood cancer diagnostics — from peripheral smear review and bone marrow analysis to integrated hemato-oncology reporting by our AIIMS DM hematopathologist.
Flow Cytometry & Immunophenotyping
Multi-color flow cytometry for leukemia/lymphoma immunophenotyping, MRD detection, PNH screening, and immune subset analysis — rapid 24-hour reporting.
Molecular Diagnostics (PCR/NGS)
PCR-based mutation analysis, gene rearrangements, NGS panels for solid tumors and hematological malignancies — precision at the molecular level.